Company / Capital Expenditures
AETHLON MEDICAL INC Capital Expenditures History
FY2014-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
-
FY2024
5-year range
$0 / $943.1K
FY2020-FY2024
Trend
-100.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $943,109 to $0 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, capital expenditures decreased 100.0% year-over-year.
- Peak capital expenditures was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0 | -100.0% |
| FY2023 | $250.9K | -73.4% |
| FY2022 | $943.1K | +521.8% |
| FY2021 | $151.7K | - |
| FY2020 | $0 | - |
| FY2018 | $0 | -100.0% |
| FY2017 | $9.3K | -43.4% |
| FY2016 | $16.4K | -82.9% |
| FY2015 | $96.1K | - |
| FY2014 | $0 | -100.0% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026